TOTAL              631
the                  Z5                  27 
in                   Z5                  22 
of                   Z5                  21 
a                    Z5                  18 
and                  Z5                  18 
draxis               Z99                 13 
to                   Z5                  13 
jubilant             E4.1+++              9 
that                 Z8                   9 
for                  Z5                   8 
it                   Z8                   8 
company              I2.1                 7 
is                   A3+                  7 
business             I2.1                 7 
's                   Z5                   7 
with                 Z5                   7 
its                  Z8                   6 
by                   Z5                   5 
said                 Q2.1                 5 
manufacturing        A1.1.1               5 
is                   Z5                   4 
an                   Z5                   4 
indian               Z2                   4 
their                Z8                   4 
contract             I2.1                 4 
that                 Z5                   4 
be                   Z5                   3 
India                Z2                   3 
offering             A9-                  3 
per                  Z5                   3 
share                S1.1.2+              3 
canadian             Z2                   3 
companies            I2.1                 3 
has                  A9+                  3 
potential            A7+                  3 
this                 M6                   3 
were                 A3+                  3 
below                Z5                   3 
could                A7+                  3 
we                   Z8                   3 
Hectorol             Z99                  3 
than                 Z5                   3 
inc.                 I2.1                 2 
has                  Z5                   2 
deal                 N5                   2 
organosys            Z99                  2 
drug                 B3                   2 
Friday               T1.3                 2 
takeover             S7.1+                2 
grow                 N3.2+                2 
last_year            T1.1.1               2 
was                  Z5                   2 
also                 N5++                 2 
acquisition          A9+                  2 
TSX                  Z99                  2 
represents           Q1.1                 2 
price                I1.3                 2 
generic              A4.2-                2 
cardiolite           Z99                  2 
nuclear              Y1                   2 
medicine             B3                   2 
was                  A3+                  2 
buyer                I2.2                 2 
opportunity          A1.4                 2 
entry                M7                   2 
into                 Z5                   2 
attractive           O4.2+                2 
high                 N3.7+                2 
one                  N1                   2 
management           S7.1+                2 
employees            I3.1                 2 
new                  T3-                  2 
pharmaceutical       B3                   2 
involved             A1.8+                2 
development          A2.1+                2 
two                  N1                   2 
offer                A9-                  2 
target               X7+                  2 
but                  Z5                   2 
they                 Z8                   2 
analyst              Y2                   2 
wrote                Q1.2                 2 
about                Z5                   2 
parts                N5.1-                2 
while                Z5                   2 
believe              X2.1                 2 
lower                M6                   2 
what                 Z8                   2 
bid                  I2.2                 2 
trading              I2.2                 2 
shares               N5.1-                2 
health               B2                   1 
struck               I3.1                 1 
us$255-million       Z99                  1 
friendly             S1.2.1+              1 
taken_over           S7.1+                1 
ltd.                 I2.1                 1 
publicly             A10+                 1 
traded               I2.2                 1 
from                 Z5                   1 
us$6                 Z99                  1 
producer             K4                   1 
announced            Q2.2                 1 
second               N4                   1 
well-known           X2.2+                1 
firm                 I2.1                 1 
as                   Z5                   1 
corporations         I2.1                 1 
fast-growing         N3.2+                1 
economy              I2.1                 1 
flex                 O3                   1 
expansion_muscles    B1                   1 
look                 A8                   1 
beyond               Z5                   1 
Asia                 Z2                   1 
international        M7                   1 
Algoma_Steel         Z1                   1 
bought               I2.2                 1 
essar                Z99                  1 
steel                O1.1                 1 
$1.85_billion        I1.2                 1 
continuing           T2++                 1 
wave                 W3                   1 
consolidation        A7+                  1 
left                 M1                   1 
steel_sector         O1.1                 1 
foreign              M7                   1 
hands                B1                   1 
have                 Z5                   1 
been                 Z5                   1 
examining            X2.4                 1 
whether              Z5                   1 
invest               I1.1                 1 
oilsands             Z99                  1 
properties           H1                   1 
northern_Alberta     Z2                   1 
proposed             Q2.2                 1 
dax                  Z99                  1 
22.4_per_cent        N5                   1 
premium              I1.1                 1 
over                 Z5                   1 
Thursday             T1.3                 1 
closing              A1.1.1               1 
which                Z8                   1 
version              A4.1                 1 
commonly             A6.2+                1 
used                 A1.5.1               1 
imaging              C1                   1 
had                  Z5                   1 
acknowledged         Q2.2                 1 
last_month           T1.1.1               1 
talks                Q2.1                 1 
unique               N5---                1 
North                M6                   1 
american             Z2                   1 
market               I2.2                 1 
regulated            A1.7+                1 
growth               N3.2+                1 
margin               N5                   1 
radiopharmaceutical  Z99                  1 
shyam                Z99                  1 
Bhartia              Z99                  1 
chairman             S7.1+                1 
managing_director    S7.1+                1 
release              A1.7-                1 
enables              S8+                  1 
consolidate          A7+                  1 
position             M6                   1 
sterile              B4                   1 
non-sterile          Z99                  1 
will                 T1.1.3               1 
become               A2.1+                1 
leading              S7.1+                1 
providers            A9-                  1 
small                N3.2-                1 
volume               N3.4                 1 
parenterals          B1                   1 
large                N3.2+                1 
pharmaceuticals      B3                   1 
biotech              Y1                   1 
north_America        Z2                   1 
excellent            A5.1+++              1 
regulatory           A1.7-                1 
track_record         X9.2+                1 
having               A9+                  1 
wealth               I1.1+                1 
experience           X2.2+                1 
expertise            X2.2+                1 
radiopharmaceuticals Z99                  1 
committed            A1.1.1               1 
supporting           S8+                  1 
through              Z5                   1 
product              O2                   1 
launches             M4                   1 
markets              I2.2                 1 
expansion            N3.2+                1 
customer_base        I2.2                 1 
integrated           A1.8+                1 
research             X2.4                 1 
in_addition_to       N5++                 1 
several              N5                   1 
locations            M7                   1 
States_in_Maryland   Z2                   1 
Washington_state     Z2                   1 
board_of_directors   S7.1+                1 
recommending         Q2.2                 1 
shareholders         I1.1                 1 
accept               A9+                  1 
analysts             Y2                   1 
quick                N3.8+                1 
say                  Q2.1                 1 
somewhat             A13.6                1 
prices               I1.3                 1 
saw                  X3.4                 1 
good                 A5.1+                1 
fit                  B2-                  1 
between              Z5                   1 
Desjardins           Z99                  1 
securities           G2.1                 1 
Maher_Yaghi          Z1                   1 
his                  Z8                   1 
calculations         N2                   1 
valued               A11.1+               1 
at                   Z5                   1 
us$6.60              Z99                  1 
if                   Z7                   1 
various              A6.3+                1 
were                 Z5                   1 
considered           X2.1                 1 
separately           A6.1-                1 
nine                 T3                   1 
per_cent             N5                   1 
our                  Z8                   1 
assessed             X2.4                 1 
takeout              Z99                  1 
valuation            I1.3                 1 
provides             A9-                  1 
fair                 G2.2+                1 
value                A11.1+               1 
current              T1.1.2               1 
investors            I1.1                 1 
regardless           A11.1-               1 
given                A9-                  1 
risks                A15-                 1 
approval             S7.4+                1 
launch               M4                   1 
sestamibi            Z99                  1 
U.S.                 Z8                   1 
volatility           A2.1+                1 
Draxis_Pharma        Z1                   1 
base                 M7                   1 
considering          Z5                   1 
possible             A7+                  1 
phase-out            Z99                  1 
2009                 N1                   1 
currently            T1.1.2               1 
greatest             A5.1+++              1 
revenue              G1.1                 1 
contributor          A9-                  1 
used_to              T1.1.1               1 
treat                S1.1.1               1 
patients             B2-                  1 
kidney_disease       B2-                  1 
most                 A13.2                1 
recent               T3-                  1 
financial            I1                   1 
report               Q2.2                 1 
production           A1.1.1               1 
volumes              N3.4                 1 
$9_million           Z99                  1 
2006                 N1                   1 
significantly        A11.1+               1 
originally           T1.1.1               1 
forecasted           Q2.2                 1 
2007                 N1                   1 
yaghi                Z99                  1 
opt_out              S1.1.3-              1 
agreement            A6.1+                1 
after                Z5                   1 
paying               I1.2                 1 
break                K1                   1 
fee                  I1.3                 1 
us$10.5              Z99                  1 
million              N1                   1 
unlikely             A7-                  1 
another              A6.1-                1 
would                A7+                  1 
emerge               M1                   1 
immediately          N3.8+                1 
provide              A9-                  1 
superior             A5.1++               1 
counter              H5                   1 
Doug_Loe             Z1                   1 
Versant              Z99                  1 
partners             S3.1                 1 
broker               I2.2                 1 
year                 T1.3                 1 
$7.50                Z99                  1 
Toronto              Z2                   1 
know                 X2.2+                1 
point                Q2.1                 1 
looks                A8                   1 
as_though            Z5                   1 
's                   A3+                  1 
drugs                B3                   1 
services             S8+                  1 
industrial           I4                   1 
chemicals            O1                   1 
conglomerate         S5+                  1 
effectively          A5.4+                1 
integrate            A1.8+                1 
capabilities         X9.1+                1 
Loe                  Z99                  1 
these                Z8                   1 
are                  A3+                  1 
areas                M7                   1 
seem                 A8                   1 
be                   A3+                  1 
underdeveloped       A5.1-                1 
in_comparison_to     A6                   1 
other                A6.1-                1 
today                T1.1.2               1 
on                   Z5                   1 
rose                 M1                   1 
$1.01                Z99                  1 
$5.95                Z99                  1 
gain                 A9+                  1 
20.5_per_cent        N5                   1 
more                 N5++                 1 
822,000              N1                   1 
